Allmed Medical Products (002950.SZ) released its performance for the first three quarters, with a net income of 0.265 billion yuan, an increase of 76.30%.

Zhitong Finance · Oct 30 09:21

Allmed Medical Products (002950.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters at 2...

Zhixun Finance APP News, Allmed Medical Products (002950.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters at 2.45 billion yuan, a 21.39% year-on-year growth. The net income attributable to the shareholders of the listed company was 0.265 billion yuan, a 76.30% year-on-year growth. The net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.244 billion yuan, a 15.22% year-on-year growth. The basic earnings per share were 0.4233 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

奥美医疗(002950.SZ)发布前三季度业绩，净利润2.65亿元，增长76.30%

Allmed Medical Products (002950.SZ) released its performance for the first three quarters, with a net income of 0.265 billion yuan, an increase of 76.30%.

Risk Disclaimer

Statement